Synthesis of DOTA-Based <sup>43</sup>Sc Radiopharmaceuticals Using Cyclotron-Produced <sup>43</sup>Sc as Exemplified by [<sup>43</sup>Sc]Sc-PSMA-617 for PSMA PET Imaging

Synthesis of DOTA-Based <sup>43</sup>Sc Radiopharmaceuticals Using Cyclotron-Produced <sup>43</sup>Sc as Exemplified by [<sup>43</sup>Sc]Sc-PSMA-617 for PSMA PET Imaging

The implementation of theranostics in oncologic nuclear medicine has exhibited immense potential in improving patient outcomes in prostate cancer with the implementation of [<sup>68</sup>Ga]Ga-PSMA-11 PET and [<sup>177</sup>Lu]Lu-PSMA-617 into clinical practice. However, the...

Full description

Saved in:
Bibliographic Details
Main Authors: Jason P. Meier, Mohammed Bhuiyan, Richard Freifelder, Hannah J. Zhang, Lucas Gonzalez, Antonino Pusateri, Hsiu-Ming Tsai, Lara Leoni, Kaustab Ghosh, Erica Markiewicz, Christopher Henning, Yuhan Zhang, Ralph Weichselbaum, Jerry Nolen, David A. Rotsch, Chien-Min Kao, Russell Z. Szmulewitz, Chin-Tu Chen, Satish K. Chitneni
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Methods and Protocols
Subjects:
theranostics
Scandium-43
Scandium-44
Scandium-47
PSMA-617
prostate cancer
Online Access:https://www.mdpi.com/2409-9279/8/3/58
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.mdpi.com/2409-9279/8/3/58

Similar Items